115 related articles for article (PubMed ID: 36577152)
1. Low-dose decitabine for refractory thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children: A pilot study.
Liu N; Zhao FY; Liang J; Shang LP; Xu XJ
Int Immunopharmacol; 2023 Feb; 115():109579. PubMed ID: 36577152
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Platelet Recovery in Myelodysplastic Syndromes With Severe Thrombocytopenia.
Tang Y; Zhang X; Han S; Chu T; Qi J; Wang H; Tang X; Qiu H; Fu C; Ruan C; Wu D; Han Y
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):217S-222S. PubMed ID: 30296835
[TBL] [Abstract][Full Text] [Related]
3. Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications.
D'Angelo CR; Hall A; Woo KM; Kim K; Longo W; Hematti P; Callander N; Kenkre VP; Mattison R; Juckett M
Leuk Res; 2020 Sep; 96():106419. PubMed ID: 32683127
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of avatrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation: A real-world data evaluation on 14 cases.
Liu E; Fang P; Xin H; Li S; Liu Y; Xu Y; Chen Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):376-385. PubMed ID: 37164921
[TBL] [Abstract][Full Text] [Related]
5. Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation.
Zhou M; Li T; Zhang P; Lai Y; Sheng L; Ouyang G
Ann Hematol; 2024 May; 103(5):1697-1704. PubMed ID: 38536476
[TBL] [Abstract][Full Text] [Related]
6. [The safety of decitabine as bridging pretreatment regimen before hematopoietic stem cell transplantation in pediatric hematological malignancies].
Fan LY; Hu SY; Xiao PF; Lu J; Li J; Yao YH; Ling J; Kong LJ; Liu H; Bian XN
Zhonghua Nei Ke Za Zhi; 2018 Sep; 57(9):679-682. PubMed ID: 30180454
[TBL] [Abstract][Full Text] [Related]
7. Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trial.
Tang Y; Chen J; Liu Q; Chu T; Pan T; Liang J; He XF; Chen F; Yang T; Ma X; Wu X; Hu S; Cao X; Hu X; Hu J; Liu Y; Qi J; Shen Y; Ruan C; Han Y; Wu D
Blood Adv; 2021 Mar; 5(5):1250-1258. PubMed ID: 33646303
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation.
Karataş A; Göker H; Demiroğlu H; Malkan ÜY; Velet M; Çınar OE; Erdoğdu B; Karadeniz M; Sayınalp N; Aksu S; Haznedaroğlu İC; Özcebe Oİ; Büyükaşık Y
Turk J Med Sci; 2022 Apr; 52(2):413-419. PubMed ID: 36161632
[TBL] [Abstract][Full Text] [Related]
9. Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children.
Masetti R; Vendemini F; Quarello P; Girardi K; Prete A; Fagioli F; Pession A; Locatelli F
Pediatr Blood Cancer; 2020 May; 67(5):e28208. PubMed ID: 32065469
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of decitabine pretreatment-based allogeneic hematopoietic stem cell transplantation affecting transplantation-related complications and prognosis in patients with malignant hematological disease.
Li L; Zhao Z; Li X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):69-75. PubMed ID: 38279480
[TBL] [Abstract][Full Text] [Related]
11. The effect of decitabine-combined minimally myelosuppressive regimen bridged allo-HSCT on the outcomes of pediatric MDS from 10 years' experience of a single center.
Gao J; Hu Y; Gao L; Xiao P; Lu J; Hu S
BMC Pediatr; 2022 May; 22(1):312. PubMed ID: 35624441
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose Decitabine for Patients With Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation: A Pilot Therapeutic Study.
Han Y; Tang Y; Chen J; Liang J; Ye C; Ruan C; Wu D
JAMA Oncol; 2015 May; 1(2):249-51. PubMed ID: 26181032
[No Abstract] [Full Text] [Related]
13. [Retrospective efficacy analysis of decitabine bridging allogeneic hematopoietic stem cell transplantation on the treatment of myelodysplastic syndrome].
Zheng H; Wang J; Zhou J; Wang P; Fu C; Wu D; Sun A; Qiu H; Jin Z; Han Y; Tang X; Ma X
Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):121-4. PubMed ID: 25778887
[TBL] [Abstract][Full Text] [Related]
14. Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation in children: Single-centre experience.
Yaman Y; Elli M; Şahin Ş; Özdilli K; Bilgen H; Bayram N; Nepesov S; Anak S
Pediatr Transplant; 2021 Aug; 25(5):e13962. PubMed ID: 33452850
[TBL] [Abstract][Full Text] [Related]
15. Conditioning Regimen of 5-Day Decitabine Administration for Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Myeloproliferative Neoplasms.
Cao YG; He Y; Zhang SD; Liu ZX; Zhai WH; Ma QL; Pang AM; Wei JL; Yang DL; Huang Y; Feng SZ; Jiang EL; Han MZ
Biol Blood Marrow Transplant; 2020 Feb; 26(2):285-291. PubMed ID: 31494229
[TBL] [Abstract][Full Text] [Related]
16. Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT.
Zhang XH; Wang QM; Zhang JM; Feng FE; Wang FR; Chen H; Zhang YY; Chen YH; Han W; Xu LP; Liu KY; Huang XJ
J Hematol Oncol; 2015 Oct; 8():116. PubMed ID: 26497387
[TBL] [Abstract][Full Text] [Related]
17. Haematologic malignancies with unfavourable gene mutations benefit from donor lymphocyte infusion with/without decitabine for prophylaxis of relapse after allogeneic HSCT: A pilot study.
Zhang R; Wang L; Chen P; Gao X; Wang S; Li F; Dou L; Gao C; Li Y; Liu D
Cancer Med; 2021 May; 10(10):3165-3176. PubMed ID: 33932107
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.
Kobos R; Steinherz PG; Kernan NA; Prockop SE; Scaradavou A; Small TN; Shukla N; Khalaf R; O'Reilly RJ; Boulad F
Biol Blood Marrow Transplant; 2012 Mar; 18(3):473-80. PubMed ID: 22079789
[TBL] [Abstract][Full Text] [Related]
19. Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome.
Pusic I; Choi J; Fiala MA; Gao F; Holt M; Cashen AF; Vij R; Abboud CN; Stockerl-Goldstein KE; Jacoby MA; Uy GL; Westervelt P; DiPersio JF
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1761-9. PubMed ID: 26055299
[TBL] [Abstract][Full Text] [Related]
20. A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia.
Zhou H; Qin P; Liu Q; Yuan C; Hao Y; Zhang H; Wang Z; Ran X; Chu X; Yu W; Wang X; Hou Y; Peng J; Hou M
Am J Hematol; 2019 Dec; 94(12):1374-1381. PubMed ID: 31591739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
